ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,406, issued on Oct. 6, was assigned to The Broad Institute Inc. (Cambridge, Mass.) and Massachusetts Institute of Technology (Cambridge, Mass.).

"CAS12B enzymes and systems" was invented by Feng Zhang (Cambridge, Mass.), Jonathan Strecker (Cambridge, Mass.), Ian Slaymaker (Cambridge, Mass.) and Sara Jones (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are systems, methods, and compositions for targeting nucleic acids. In certain example embodiments, non-naturally occurring or engineered RNA-targeting systems contain an RNA-targeting Cas12b effector protein and at least one targeting nucleic acid component like a gui...